0

500218

JKPHARMA

img img img img
No Data Available

J.K.PHARMACHEM LTD. Share Price Update

As of the latest trading session, J.K.PHARMACHEM LTD. is trading at ₹1.79, up by ₹0.00 or 0.00% from its previous close. The stock has moved between ₹1.76 and ₹1.90 today. Over the past year, the stock has delivered a return of 0.00%. In the last month, it has returned -9.59%.

Investment Returns

Over 1 Month -9.59% Over 3 Months -21.14% Over 6 Months 0.00% Over 1 Year 0.00%
demotext Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

J.K.PHARMACHEM LTD. fundamentals


  • Market cap (Cr) [-]
  • P/E Ratio (TTM) [-]
  • Beta [-]
  • Book Value / share [-]
  • Return on equity [-]%
  • EPS (TTM) [-]
  • Dividend yield [-]%
  • Net profit/quarter (Cr) [-]
info icon alternate text
  • Market cap (Cr) 0.0
  • P/E Ratio (TTM) 0.0
  • Beta 0.0
  • Book Value / share 0.0
  • Return on equity 0.0%
  • EPS (TTM) 0.0
  • Dividend yield [-]%
  • Net profit/quarter (Cr) 0.0
info icon alternate text

J.K.PHARMACHEM LTD. Financials

  • Key Results
  • Key Ratios
  • Balance sheet
  • Cash Flow
  • Competition
info-icon
Revenue
Net income
Particulars SEP 2005 (Values in Cr)
Book Value / Share -5.97
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 806.70
EBITDA Margin -67.37
Particulars SEP 2004 (Values in Cr)
Book Value / Share -3.98
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 4.13
EBITDA Margin -31.24
Particulars SEP 2003 (Values in Cr)
Book Value / Share 1.98
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 2.18
EBITDA Margin 10.78
Particulars SEP 2002 (Values in Cr)
Book Value / Share 2.88
ROE % 5.29
ROCE % 6.13
Total Debt to Total Equity 2.38
EBITDA Margin 19.65
Particulars SEP 2001 (Values in Cr)
Book Value / Share 1.16
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 2.30
EBITDA Margin 6.67
Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
AMBALAL SARABHAI ENT L 33.14 14.35 1.72 253.96 23.12 40.44
BLISS GVS PHARMA LTD 269.30 25.75 2.51 2848.90 105.05 280.20
CIPLA LTD 1308.05 22.22 3.20 105662.01 1165.55 1672.20
FERMENTA BIOTECH LIMITED 312.30 10.39 2.35 919.13 252.15 399.00
GLAXOSMITHKLINE PHARMA LT 2410.60 40.60 23.91 40837.02 2218.00 3515.95
Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
AMBALAL SARABHAI ENT L 33.14 31.87 4.61 253.96 23.12 40.44
AMRUTANJAN HEALTH CARE LTD. 581.40 29.07 4.91 1680.86 490.00 789.95
ASTRAZENECA PHARMA INDIA LTD. 8457.85 101.64 26.46 21144.63 7630.00 10653.05
BLISS GVS PHARMA LTD 269.30 36.69 2.58 2848.90 105.05 280.20

J.K.PHARMACHEM LTD. shareholding pattern

Holding
Name Shares Category

J.K.PHARMACHEM LTD. Technicals Summary

  • EMA & SMA
  • Resistance and Support
  • Delivery and Volume
  • Beta
  • Price Change Analysis
1.79 -1.64 redarrow
red-green-graph indicator
0 Bearish
0 Bullish
  • 5 Days 0.00
  • 26 Days 0.00
  • 10 Days 0.00
  • 50 Days 0.00
  • 12 Days 0.00
  • 100 Days 0.00
  • 20 Days 0.00
  • 200 Days 0.00
0.0 PIVOT
First Support 0.0 First Resistance 0.0 Second Support 0.0 Second Resistance 0.0 Third Support 0.0 Third Resistance 0.0
RSI 0.0 ADX 0.0 MACD 0.0 Williams % R 0.0 Commodity Channel Index (CCI) 0.0
Date [-] Week 0.0 Same Day 0.0 Month 0.0
1 Year 0.0 3 Year 0.0
Over 1 Month
-9.59% down
Over 1 Year
0.00% down
Over 3 Months
-21.14% down
Over 3 Years
0.00% down
Over 6 Months
0.00% down
Over 5 Years
0.00% down

J.K.PHARMACHEM LTD. Corporate Actions

Top Gainers

Top Losers

J.K.PHARMACHEM LTD. Share Price

Jointly promoted by J K Industries and TIDCO, J K Pharmachem manufactures drugs and pharmaceuticals. It entered the capital market in Oct.'94 to part-finance the setting up of a plant to manufacture 1250 MMU P.a of pencillin-G, based on a microbial strain from the technical collaborators -- IGC (Cyprus), Cyprus -- a wholly-owned subsidiary of ICN Galenika. Commercial production at this plant commenced in Oct.'95.

The company has a tie-up with ICN Galenika, part of the ICN Pharmaceuticals group (one of the pioneering manufacturers of pencillin-G), to set up a 1250-mmu capacity plant.

It has already produced international standard penicillin with Indian raw materials, at its collaborator's plant which is among the best in the world. In addition, J K Pharmachem had set-up its own R&D activity well in advance for future development in the field of bio-technology. A pilot plant is also being established for this purpose at Cuddalore, Tamilnadu.

The company also plans to diversify into speciality fermentation products. It has also started production of Penicillin-V and is the only one in India to produce this bulk active.

During 1999-2000, the company started the production of Penicillin V and is the only producer of this important bulk active in India. The accumulated losses of the company having exceeded 50% of the peak networth of the company in the immediately preceding four financial years, the company took the necessary steps of SICA, 1985. The company developed an in-house and launched viz JKZyme, an environment new product of paper & pulp. Commercial trails are under way in India and abroad.

The company has produced 1192 MMU of Penicillin-G during the financial year 2003-04 and retained its status as the second largest producer with a market share of 24%.

Parent organization Singhania Hari Shankar
NSE symbol JKPHARMA
Founded 1990
stock
Trade stocks with ease

Sign-in to trade with your demat account, or set up a new demat account for free

Board Of Directors

Left Arrow
Right Arrow

Similar stocks

Left Arrow
Right Arrow

Frequently Asked Questions

What is the Current Share Price of J K Pharmachem Ltd?

Answer Field

J K Pharmachem Ltd share price is for NSE ₹ 1.90 & for BSE ₹ 1.79 as on Sep 08 2006 12:00 AM.

What is the Market Cap of J K Pharmachem Ltd Share?

Answer Field

The market cap of J K Pharmachem Ltd for NSE ₹ 0.00 & for BSE ₹ 0.00 as on Sep 08 2006 12:00 AM.

What is the 52 Week High and Low of J K Pharmachem Ltd?

Answer Field

The 52 Week High and Low of J K Pharmachem Ltd for NSE is ₹ 1.89 and ₹ 0.00 and for BSE is ₹ 1.90 and ₹ 0.00.

What is 1 year return for J K Pharmachem Ltd?

Answer Field

The 1 year returns on the stock has been 0.00%.

What is the P/E Ratio of J K Pharmachem Ltd Share?

Answer Field

As on Sep 08 2006 12:00 AM the price-to-earnings (PE) ratio for J K Pharmachem Ltd share is 0.0.

What is the PB ratio of J K Pharmachem Ltd Share?

Answer Field

As on Sep 08 2006 12:00 AM, the price-to-book (PB) ratio for J K Pharmachem Ltd share is 0.0.

How to Buy J K Pharmachem Ltd Share?

Answer Field

You can trade in J K Pharmachem Ltd shares with Bajaj Broking by opening a demat account.

How to Buy J K Pharmachem Ltd Share on Bajaj Broking App?

Answer Field

To buy J K Pharmachem Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “J K Pharmachem Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

close-image

Get Free Demat Account*

+91
close-img

Authorise with OTP

Enter the 4-Digit OTP sent to
edit
OTP expires in 00:59
banner-icon

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|

Please Enter Mobile Number

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|